Objective To identify factors associated with prolonged maternal breast milk (BM) provision in very low birth weight (VLBW) infants.
, Daniel K. Benjamin, Jr, MD, PhD 1, 5 , and Rachel G. Greenberg, MD, MB, MHS 1, 5 Objective To identify factors associated with prolonged maternal breast milk (BM) provision in very low birth weight (VLBW) infants.
Study design This was a cohort study of VLBW infants who initially received maternal BM and were born at one of 197 neonatal intensive care units managed by the Pediatrix Medical Group from 2010 to 2012. We used multivariable logistic regression to identify demographic, clinical, and maternal factors associated with provision of maternal BM on day of life (DOL) 30 and at discharge.
Results Median gestational age for all infants was 28 weeks (25 th , 75 th percentiles: 26, 30) , and median maternal age was 28 years (23, 33) . Of 8806 infants, 6261 (71%) received maternal BM on DOL 30, and 4003 of 8097 (49%) received maternal BM at discharge to home. Predictors of maternal BM provision at DOL 30 included increased maternal age, white maternal race, absence of history of necrotizing enterocolitis or late-onset sepsis, higher household income, lower education level, lack of donor BM exposure, and lower gestational age.
Conclusions Our results suggest that maternal-infant demographic and clinical factors and household neighborhood socioeconomic characteristics were associated with provision of maternal BM at 30 postnatal days to VLBW infants. Identification of these factors allows providers to anticipate mothers' needs and develop tailored interventions designed to improve rates of prolonged maternal BM provision and infant outcomes. V ery low birth weight (VLBW, <1500 g birth weight) infants often do not receive maternal breast milk (BM) despite its known benefits over infant formula or pasteurized donor human milk. [1] [2] [3] These benefits include lowered risks of sepsis, necrotizing enterocolitis (NEC), retinopathy of prematurity, and bronchopulmonary dysplasia, as well as improved neurodevelopmental outcomes. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] This information, along with improvements in neonatal intensive care unit (NICU)-specific interventions, have resulted in increased rates of lactation initiation, and most mothers of VLBW infants make the decision to provide maternal BM soon after delivering a VLBW infant. [16] [17] [18] [19] Despite this, VLBW infants are less likely than their normal birth weight counterparts to receive maternal BM at hospital discharge. 1, 2 Although the amount of maternal BM received during critical exposure periods in the NICU hospitalization has been linked to the reduction in the abovementioned morbidities, little is known about provision of maternal BM in the NICU aside from initiation and discharge rates. 20 Of particular interest is the first 30 days post-birth, as VLBW infants transition from intrauterine to extrauterine nutrition and are at the greatest risk for morbidities that are potentially preventable with high-dose maternal BM feedings. Furthermore, there is evidence of a 3-fold increase in the number of mothers choosing not to provide maternal BM after 30 days of age compared with earlier in the NICU hospitalization. 21 Previous work has identified associations between provision of maternal BM in the NICU and infant characteristics (eg, gestational age or birth weight), maternal characteristics (eg, maternal age or maternal race), and environmental factors (eg, site of care, social support, or access to breastfeeding education). [22] [23] [24] [25] [26] However, many of these studies failed to distinguish between VLBW and term infants and vary with respect to the duration of maternal BM provision during the hospitalization, such as initiation or maintenance to hospital discharge. 27, 28 Leveraging a large, multicenter, electronic health record-derived database, the purpose of this study was to identify factors that predicted prolonged provision
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Breast milk DOL Day of life NEC Necrotizing enterocolitis NICU Neonatal intensive care unit VLBW Very low birth weight of maternal BM among VLBW infants initially exposed to maternal BM. For this report, we examined which of these factors predicted continued provision of maternal BM through 30 days of age and to discharge.
Methods
We conducted a prospective cohort study of electronic health records from 197 NICUs managed by the Pediatrix Medical Group in the US from January 1, 2010 to December 31, 2012. The Pediatrix Medical Group Clinical Data Warehouse includes data on multiple aspects of care obtained from admission notes, daily progress notes, and discharge summaries and includes maternal history, demographic data, medications, laboratory results, diagnoses, and procedures. 29 Infants were eligible for inclusion based on the following criteria: birth weight <1500 g; receipt of maternal BM at any time prior to 30 days of life (DOL); NICU discharge between 2010 and 2012, with availability of maternal address linking to census block groupspecific geospatial data; inborn; and alive on DOL 30. Infants who were discharged or transferred prior to DOL 30 and those missing data on BM provision on DOL 30 were excluded. Variables considered as potentially associated with prolonged provision of maternal BM included donor BM intake, gestational age, sex, 5-minute Apgar score, NEC diagnosis prior to DOL 30, late-onset sepsis from DOL 4-29, cesarean delivery, maternal race, maternal age, and use of prenatal care. In addition, we used each mother's home address to identify her corresponding US census block, which was then linked to block group-specific geospatial data, including annual income, educational attainment, presence of single-female households, and straight-line distance to the nearest NICU. This study was approved by the Duke University Institutional Review Board with a waiver of written informed consent.
Definitions
Provision of maternal BM at DOL 30 was defined as receipt of maternal BM by any enteral route on DOL 30. Infants receiving nothing by mouth on DOL 30 were included if they received maternal BM on the first day of resumed enteral feeding after DOL 30. Provision of maternal BM at discharge was defined as receipt of maternal BM by any enteral route on the day of or the day before discharge home. We defined donor BM provision as receipt of BM originating from a human milk bank at any point prior to DOL 30. NEC diagnoses were obtained from the medical record, defined according to the attending neonatologist, and included medical or surgical NEC. Late-onset sepsis was defined as a positive bacterial culture for blood or cerebrospinal fluid from DOL 4-29, including probable and definite episodes attributable to coagulase-negative Staphylococcus but excluding other organisms likely to be contaminants. 30 
Statistical Analyses
Descriptive statistics (medians, 25th and 75th percentiles, counts, and percentages) were used to summarize data. We performed unadjusted analyses between groups, using the Wilcoxon rank-sum test for continuous variables and the c 2 test for categorical variables where appropriate. The primary outcome was provision of maternal BM at DOL 30. We used multivariable logistic regression to evaluate the association of all demographic, clinical, and maternal variables with provision of maternal BM at DOL 30. We also examined provision of maternal BM by site among those that discharged at least 20 infants during the study period. We divided sites into quartiles according to the percentage of infants who received maternal BM at DOL 30 and reported site characteristics by quartile, including volume of infants, gestational age, and percentage of infants receiving donor BM. As a secondary analysis among infants who were discharged home, we used multivariable logistic regression to evaluate the association of the same covariates with provision of maternal BM at discharge. P values of <.05 were considered statistically significant. Analyses were conducted using Stata 15.1 software (StataCorp LLC, College Station, Texas).
Results
A total of 8806 infants were included in the analysis (Figure 1 ). The median gestational age was 28 (25th, 75th percentiles: 26, Table I) . Among the 102 sites discharging ≥20 infants during the study period, the median percentage of infants receiving maternal BM at DOL 30 was 71% (65%, 81%). We observed significant variability across sites in the proportion of infants receiving maternal BM at DOL 30, with 7 (7%) sites reporting <50% of infants and 6 (6%) sites reporting ≥90% of infants receiving maternal BM at 30 days of age, respectively (Figure 2 ). There were few noticeable trends in unit volume, gestational age, and provision of donor BM according to the proportion of infants receiving maternal BM at DOL 30 at each site (Table II) . Of the 102 sites discharging ≥20 infants during the study period, 95 of 102 (93%) sites provided donor BM for at least 1 infant. On adjusted analysis, women 20-29 years of age (OR 1.54, 95% CI 1.31-1.82, P = .001) and 30-39 years of age (OR 1.90, 95% CI 1.59-2.27, P < .001) were more likely to provide maternal BM, compared with women <20 years of age (Table III) . Black race was associated with less provision of maternal BM on DOL 30 than white race (OR 0.58, 95% CI 0.51-0.66, P < .001). Provision of maternal BM on DOL 30 did not differ between Hispanic and "other" race/ethnicity and white race.
Compared with infants born at <26 weeks of gestation, those born at 26-28 weeks of gestation (OR 0.79, 95% CI 0.68-0.93, P = .004), 29-32 weeks of gestation (OR 0.60, 95% CI 0.51-0.71, P < .001), and >32 weeks of gestation (OR 0.61, 95% CI 0.42-0.88, P = .008) were less likely to receive maternal BM at 30 days of age. Infants receiving any donor BM prior to DOL 30 were less likely to receive maternal BM on DOL 30 than those not exposed to donor BM (OR 0.60, 95% CI 0.53-0.67, P < .001). Infants with a history of NEC (OR 0.67, 95% CI 0.52-0.86, P = .002) or late-onset sepsis (OR 0.81, 95% CI 0.66-0.99, P = .04) were less likely to receive maternal BM on DOL 30. Compared with mothers residing in areas with a median income of <$30 000, those residing in areas with median incomes of $30 000-$59 999 (OR 1.28, 95% CI 1.10-1.48, P = .001), and >$60 000 (OR 1.37, 95% CI 1.11-1.68, P = .003) were more likely to provide maternal BM through to DOL 30. Mothers residing in areas in which ≥30% of households were led by a single female individual were less likely to provide maternal BM through to discharge (OR 0.80, 95% CI 0.67-0.96, P = .02). Mothers residing in areas in which ≥30% of individuals did not have a high school education or a general equivalency diploma (GED) were less likely to provide maternal BM through to DOL 30 (OR 0.69, 95% CI 0.58-0.83, P < .001).
A total of 8097 infants were discharged home, and 4003 of 8097 (49%) were receiving maternal BM at discharge (Table IV; available at www.jpeds.com). Covariates that were predictive of maternal BM provision at DOL 30 were similar to those that were predictive of maternal BM provision at discharge (Table III) . In contrast to our findings at DOL 30, however, those born at 26-28 weeks of gestation (OR 1.32, 95% CI 1.12-1.55, P = .001), 29-32 weeks of gestation (OR 2.10, 95% CI 1.78-2.48, P < .001), and >32 weeks of gestation (OR 2.66, 95% CI 1.82-3.88, P < .001) were more likely to receive maternal BM at discharge than infants born at <26 weeks of gestation. In addition, higher Apgar scores were associated with increased likelihood of receiving maternal BM at discharge (Table IV; available at www.jpeds.com).
Discussion
We studied factors predicting continued maternal BM provision in VLBW infants through to DOL 30 and identified the following significant variables: increased maternal age, white maternal race, absence of history of NEC or late-onset sepsis, higher household income, lower education level, lack of donor BM exposure, and lower gestational age. Consistent with a study performed at Pediatrix NICUs in 1999-2000, we found that provision of maternal BM varied substantially among sites. 25 The variability in maternal BM provision among sites supports the notion that there are modifiable factors that can be influenced by interventions to increase maternal BM provision. Our findings can inform such targeted interventions to decrease barriers to continued maternal BM provision in this population of infants, who remain less likely to receive maternal BM at 6 months of age than term counterparts despite the World Health Organization's recommendation of exclusive BM feedings for all infants during the first 6 months of life. 31 These interventions are increasingly important, as ingestion of maternal BM in premature infants has previously been shown to have dose-dependent positive effects on post-NICU hospital readmissions as well as neurodevelopmental outcomes. 14, 15 Understanding which factors predict sustained maternal BM provision can inform structured support programs specifically tailored to the demographics of the individual NICU.
Whereas previous studies have focused largely on breastfeeding rates in the NICU or at NICU discharge, we chose to examine maternal BM provision at DOL 30 to identify factors uniquely predictive of continued provision of maternal BM among mothers who initiated lactation. Furthermore, we speculate that the 30-day time point might serve as an appropriate marker for measuring maternal commitment to continued maternal BM provision or direct breastfeeding. In addition, many infants have achieved a substantial volume of milk intake by DOL 30. Among infants who received any maternal BM, we observed that 71% received maternal BM at DOL 30 and 49% at discharge, lower than the 60% maternal BM provision rate at NICU discharge observed by Brownell et al. 2 The Brownell study involved a single-center cohort of infants cared for at a NICU with a well-established lactation program; we were unable to quantify the degree of lactation support in the NICUs in our study. These results may prove useful in the development of educational programs aimed at encouraging BM provision up to and postdischarge. Lactation counseling for mothers of VLBW infants is often aimed at easing mothers' anxiety about their children's health and promoting lactation initiation. In contrast, efforts to promote continued maternal BM provision in the NICU should involve the entire NICU team and perhaps emphasize achievable short-term goals, such as initiation of pumping in the first postnatal hours, enhancing skin-to-skin contact, production and provision of colostrum to NICU infants, and optimizing postpartum and NICU staff support of mothers' efforts on sustained lactation up to DOL 30. 32 Acknowledging the challenges and designing interventions to support mothers with lower incomes (eg, facilitating the search for and purchasing of pumps) may also improve rates of 30-day provision of maternal BM. 33 Consistent with previously published findings, we found that maternal race, maternal age, education level, married status, and median household income in the census block where a family lives are associated with maternal BM provision in VLBW infants at both DOL 30 and discharge. A 2011 retrospective study concluded that black mothers, mothers of lower socioeconomic status, and younger mothers had less success in continuing maternal BM provision at discharge from the NICU. 24 Although this study did not specifically examine maternal BM provision on DOL 30, similarities between the contributing factors support our conclusion that race, maternal age, and income are important predictors of longer-term maternal BM provision in VLBW infants. Some or all of these factors also may be correlated with more direct barriers to prolonged maternal BM provision, such as limited access to prenatal care, NICU-specific breastfeeding education and equipment (such as hospital-grade electric breast pumps), postpartum support, and resources required to provide maternal BM to a nonbreastfeeding preterm infant. A 2011 report by the Centers for Disease Control and Prevention cited several racial disparities in access to maternity care practices known to support breastfeeding. 34 Racial differences in maternal BM provision rates might also reflect cultural influences on breastfeeding experiences, knowledge, and perception. 21, [35] [36] [37] Interestingly, extreme prematurity (gestational age <26 weeks) was associated with increased likelihood of maternal BM provision at DOL 30, but decreased likelihood of maternal BM provision at discharge. This finding agrees with results of previous studies. For instance, a 2003 retrospective study of 42 891 NICU infants determined that infants of older gestational age were more likely to receive maternal BM at discharge. 25 However, this older study included term infants in addition to preterm infants. Compared with late preterm and term infants, very preterm infants may be at higher risk for absence of maternal BM exposure at discharge given their longer length of hospital stay. Another study has documented findings similar to our results at DOL 30; Colaizy et al demonstrated an increased likelihood of providing maternal BM for at least 4 weeks in infants with a gestational age of <32 weeks compared with more mature infants admitted to the NICU. 18 We propose 2 possible explanations for our finding that the least mature infants in our study had an increased likelihood for maternal BM at DOL 30. First, because their children were at risk for a number of complications, mothers of the least-mature infants may have received stronger counseling and greater support for providing maternal BM from their NICU caregivers, including more targeted provision of pumps and other time-related resources, thus, increasing the likelihood of maternal BM provision. It is also possible that smaller and less mature infants required lower volumes of milk than larger infants, leading to a longer length of time that a stored maternal BM supply was available for use.
A history of NEC or late-onset sepsis in the first 30 days of life was associated with decreased likelihood of maternal BM provision. Critical illness in the NICU can be a significant maternal stressor, which has been associated previously with decreased BM provision. 38 In addition, infants without maternal BM receipt at DOL 30 may have lacked the protective effect of maternal BM in earlier weeks, possibly leading to an increased risk of NEC and late-onset sepsis. 8, 39 We also found that receipt of donor BM prior to DOL 30 is associated with decreased likelihood of maternal BM provision at DOL 30 and at discharge. This observation is consistent with the notion that infants receiving donor BM in the first few weeks of life (potentially indicating a problem with maternal BM supply) are likely to continue receiving donor BM at DOL 30. Although several previous studies have disagreed with our findings and have shown that donor BM does not reduce rates of maternal BM provision, another has suggested that maternal BM provision, particularly in lowincome black women, can be negatively impacted by donor BM programs. 3, 40 In addition, because donor BM use can occur because of maternal complications of pregnancy or preexisting conditions that preclude sufficient maternal BM provision, there is a need for NICU-specific lactation care by personnel who can diagnose and manage these complications. Although donor BM has been shown to have advantages over formula, 41 the advantages of maternal BM over both donor BM and formula have been well-described in the literature. 42 Consistent with a previous single-center study, 22 geographic distance to the nearest NICU was not a significant predictor of maternal BM provision at DOL 30. We had hypothesized that increased distance between the home and the NICU would increase mother-infant separation and, therefore, represent a barrier to consistent and prolonged provision of maternal BM. We had also hypothesized that mothers living far away from a NICU might have less access to prenatal care and less exposure to breastfeeding-promotion programs. Although we excluded outborn infants from our sample to control for the fact that many infants born at smaller centers are transferred to larger centers, 32% of mothers in our study lived ≥20 miles from the NICU. We did not observe a significant difference in maternal BM provision by these mothers at DOL 30 or discharge. It is possible that other factors not available in our dataset, such as access to private or public transportation, could have an impact on maternal BM provision.
The large number of included infants and the diverse patient population are strengths of our study. We were able to show a substantial variation in maternal BM provision among a large number of included study sites. Our study was limited by a lack of information describing the existence of NICU-specific, evidence-based lactation support programs and the number of lactation specialists available. We also could not determine whether breast pumps were provided for mothers or whether mothers were exposed to medications or had medical diagnoses that may have affected maternal BM supply. An additional limitation of this study is the use of maternal BM feedings at DOL 30 to represent mothers' continued provision of maternal BM. It is possible that we may have overestimated the maternal BM provision rate by including infants who continued to receive stored frozen maternal BM from earlier in the NICU hospitalization. We were also unable to quantify the volume of maternal BM received, which prevented us from examining what factors affect the establishment of a full milk supply, and the use of fortifiers, which may have affected the volume of maternal BM required. Furthermore, the variables of maternal education, household income, and single female household were all based on census data (referring to the block group in which with the mother's home address is located and US census data for that location). Of course, a mother's personal demographics may not always match the demographics of her surrounding region. However, insight by providers into the socioeconomic demographics of a community may be important for them to implement the most innovative, cost-effective strategies to promote sustained maternal BM provision.
Going forward, significant work remains to elucidate barriers to mothers' ability to provide maternal BM for their VLBW infants. A survey-based, prospective study gathering and aggregating data derived from maternal motivation surveys in addition to providers' attitudes and available NICU resources THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 202 may provide additional insight into mothers' reasons for providing maternal BM to their VLBW infants. In addition, the variation in maternal BM provision among sites in our study indicates that some NICUs excel at acquiring and feeding human milk but others do not. In-depth studies of individual centers are needed to determine differences in NICUspecific, evidence-based lactation care. ■ Submitted for publication Mar 12, 2018 T he authors present the case of a 10-year-old male patient who developed palpable purpura of the lower extremities following streptococcal infection. The rash recovered spontaneously, but 2 weeks later he developed a second "wave" that progressed to ischemic gangrene lesions of the toes. Coagulation tests were normal. The lesions were unresponsive to systemic (intravenous and oral) corticosteroids but responded to heparin, with full recovery within 6 months.
I wish to highlight issues regarding the nomenclature and treatment of this condition. The name used by the authors, anaphylactoid purpura, indicates an allergic etiology perhaps related to eosinophil infiltrates sometimes found within the blood vessel wall. Today, it is clear that the pathogenesis of this vasculitis is not related to allergic inflammatory pathways. The most common term used for this condition is Henoch-Schönlein purpura, named after 2 physicians who were among the first to describe various manifestations of this condition. In recent years, the American College of Rheumatology has decided to move to names based on the disease pathogenesis rather than on persons. Hence, Henoch-Schönlein purpura has been renamed IgA vasculitis, based on the involvement of defective IgA in the disease pathogenesis and IgA staining found in skin and renal biopsies by immunofluorescence.
The issue of how to treat IgA vasculitis is still debated, particularly the role of corticosteroids. Currently, corticosteroids are used mainly for symptomatic treatment of severe gastrointestinal manifestations or scrotal edema. Based on several controlled studies, corticosteroids do not prevent renal disease 1 or affect possible progression to nephrotic syndrome or renal insufficiency. However, heparin, used in this case for pending gangrene, has been shown to be beneficial for preventing progression of renal disease in a controlled study. 1 Although there are no controlled studies, severe renal disease is treated, like in other types of vasculitis, with combinations of corticosteroids and various regimens of immunosuppressive medications.
There are even fewer data on the treatment of persistent or severe isolated skin disease, as discussed in this report. The most common protocols include use of colchicine and/or dapsone. Systemic corticosteroids are discouraged. Data presented as n (%). *Percentages or medians refer to individuals living in the maternal census tract.
